PT Bio Farma: all 51 studies
Page 1 of 1. Open to participants first (7), then studies with results posted, then the rest; newest registration first within each.
- Cy-Tb for Detecting Mycobacterium Tuberculosis Infection in Indonesian PopulationNot yet recruitingNCT07929285Not applicable
- Study Interchangeability Hep-B Vaccine Administered at Birth DoseNot yet recruitingNCT07854847Phase 3
- Immunogenicity and Safety of HPV-4 Vaccine With or Without Td Vaccine in ChildrenNot yet recruitingNCT07824310Phase 3
- A Phase I Study of Lipovaxin Tuberculosis Vaccine in Adult Healthy PopulationsRecruitingNCT07647107Phase 1
- Long-Term Protection of Vi Antibodies Induced by Bio TCV in Indonesian Population Compared to PQed TCVNot yet recruitingNCT06921460
- Phase I/II, Open Label, Randomized, Safety and Immunogenicity Following DTwP-Hepatitis B-Hib-IPV Vaccine (Bio Farma) in Indonesian InfantsNot yet recruitingNCT06690515Phase 1/2
- Immunogenicity and Safety Following In-House Recombinant Hepatitis B Vaccine in Indonesian Population (Phase III)Not yet recruitingNCT05482295Phase 3
- Pharmacokinetic Properties of 200 and 400 mg Acyclovir Tablet in Indonesia Healthy SubjectCompletedNCT04988646Not applicableResults posted
- Bioequivalence Study of Furosemide 40 mg Tablet in 24 Indonesian Healthy VolunteersCompletedNCT04982874Not applicableResults posted
- Post Authorization Safety Profile of Booster IndoVac COVID-19 VaccinationCompletedNCT06690502
- Effectiveness & Safety of Ovine Enoxaparin Sodium to Originator Enoxaparin in Non-ST-Segment Elevation ACS PatientsCompletedNCT06114641Phase 4
- Detection of High-Risk HPV in Urine and Cervical Swab Specimen Using HPV Diagnostic Kit (Bio Farma)CompletedNCT06111911Not applicable
- Post Marketing Surveillance of Diphtheria Antitoxin (DAT)CompletedNCT06053853Phase 4
- Post Authorization Safety Study Moderna COVID-19 Primary VaccineCompletedNCT06006858
- Homologous Booster Study of COVID-19 Protein Subunit Recombinant VaccineCompletedNCT05933278Phase 2
- Heterologous Booster Study of COVID-19 Protein Subunit Recombinant Vaccine in Children 12-17 Years of AgeCompletedNCT05727215Phase 2
- Preventive Care System Application Effectiveness Study on the Treatment of Diabetic Patients in BandungStatus unknownNCT05657769Not applicable
- Safety and Immunogenicity of SARS-CoV-2 Protein Subunit Recombinant Vaccine in Healthy ChildrenCompletedNCT05546502Phase 3
- Booster Study of COVID-19 Protein Subunit Recombinant VaccineCompletedNCT05525208Phase 2
- Immunogenicity and Safety of DTP-HB-Hib Using New Hepatitis B Bulk (Bio Farma)WithdrawnNCT05482282Phase 3
- Immuno-bridging Study of COVID-19 Protein Subunit Recombinant VaccineCompletedNCT05433285Phase 3
- Safety and Immunogenicity Study of COVID-19 Protein Subunit Recombinant VaccineCompletedNCT05313035Phase 2/3
- Safety and Immunogenicity Study of COVID-19 Protein Subunit Recombinant Vaccine Adjuvanted With Alum+CpG 1018CompletedNCT05228613Phase 1
- Safety & Immunogenicity of Booster SARS-CoV-2 Vaccine (Vero Cell)Status unknownNCT05172193Phase 2
- The Immunogenicity, Safety, and Effectiveness of the COVID-19 Inactivated VaccineStatus unknownNCT05126550
- Safety and Tuberculin Conversion Following BCG VaccinationCompletedNCT05124340Phase 2
- Safety and Immunogenicity of SARS-CoV-2 Protein Subunit Recombinant VaccineCompletedNCT05067894Phase 1
- Safety Profile Following Inactivated COVID-19 Vaccine in Healthy Adults Aged >18 Years in IndonesiaCompletedNCT05037227
- Persistence and Long-Term Protection of Vi Antibodies Induced by Vi-DT Conjugate Vaccines in IndonesianCompletedNCT04741828Phase 2/3
- Efficacy, Safety and Immunogenicity Study of SARS-CoV-2 Inactivated VaccineCompletedNCT04508075Phase 3
- Safety and Immunogenicity Following Recombinant Hepatitis B (Bio Farma) Vaccine in Adults & ChildrenCompletedNCT04188223Phase 1
- Efficacy, Safety and Immunogenicity of Rotavirus RV3 Vaccine (Bio Farma) in NeonatesCompletedNCT04185545Phase 3
- Immunogenicity & Safety of Bio Farma's Measles-Rubella (MR) Vaccine in Indonesian Infants (Bridging Study)CompletedNCT04183114Phase 2/3
- Comparison of Immunogenicity and Safety of DTP-HB-Hib (Bio Farma) With Pentabio® Vaccine Primed With Recombinant Hepatitis BCompletedNCT04071379Phase 3
- Immunogenicity and Safety of Vi-DT (Diphtheria Toxoid) Typhoid Conjugate Vaccine (Phase III)CompletedNCT04051268Phase 3
- Protectivity and Safety Following Recombinant Hepatitis B VaccineCompletedNCT03919578Phase 2/3
- Reactogenicity and Protectivity Following Measles- Rubella (MR) Routine Immunization in Indonesian Infants and ChildrenCompletedNCT03680417Phase 4
- Safety and Immunogenicity of Rotavirus (Bio Farma) Vaccine in Adults, Children & NeonatesCompletedNCT03462108Phase 1
- Safety and Immunogenicity of Vi-DT Typhoid Conjugate Vaccine in Indonesian Adults, Adolescents, Children and InfantsCompletedNCT03460405Phase 2
- Safety Profile Following Td Vaccination in Indonesian Pregnant WomanCompletedNCT03383653
- Protectivity and Safety of Quadrivalent Influenza HA Vaccine in Indonesian PopulationCompletedNCT03336593Phase 2
- Immunogenicity and Safety Profile of Primary Dose of bOPV Bio Farma Given Simultaneously With Pentabio And IPVCompletedNCT03310073Phase 4
- Safety and Immunogenicity of Vi-DT Typhoid Conjugate Vaccine (Bio Farma) in Adults and Children (Phase I)CompletedNCT03109600Phase 1
- Antibody Persistence, Immune Response and Safety After Doses of Pentabio VaccineCompletedNCT02095314Phase 2/3
- Safety Profile Following Pentabio Vaccination in Indonesian InfantsCompletedNCT02093286
- Evaluation on Immunogenicity and Safety Profile of Trivalent OPV (tOPV Bio Farma)CompletedNCT02093273Phase 2
- Immunogenocity and Safety of Flubio (Influenza HA) Vaccine in Infants and Children (Bridging Study)CompletedNCT02093260Phase 2/3
- Protectivity and Safety of DTP/HB/Hib (Bio Farma) Vaccines in Infants, Batch Consistency, Multi Center TrialCompletedNCT01986335Phase 3
- Immunogenicity and Safety of DTP/HB/Hib (Bio Farma)Compared to DTP/HB Given Simultaneously With Hib(Registered)VaccineCompletedNCT01986322Phase 2
- The Safety and Immunogenicity of DTP/Hepatitis B 10ug Hib Vaccine (Bio Farma)CompletedNCT01977196Phase 1
- Safety of Hib Vaccine (Bio Farma)CompletedNCT01977170Phase 1